Edesa Biotech is trading at $5.44 (up 5.3%) in after-hours sessions, rebounding from a 3.5% regular-session drop to $5.17 on August 5, 2026.

  • The move occurs despite a lack of fresh earnings, SEC filings, or material company-specific headlines to justify the price action.
  • The after-hours strength is likely driven by thin liquidity and routine extended-hours volatility rather than a clear fundamental catalyst.